Healthcare

CANbridge Pharma, a developer of specialty healthcare products designed to treat critical medical conditions, announced the completion of a US$98 million Series D financing. The round was led by General Atlantic, a leading global growth equity firm, and WuXi AppTec.

Men’s health management platform Menxlab announced the completion of an angel financing of tens-of-millions yuan from Gaorong Capital, GF Xinde Investment and other institutions.

On June 2, Assure Tech’s application for Science and Innovation Board (STAR Market) has been accepted.
The funds raised from this listing will mainly be used to expand the production capacity of Assure Tech.

Lachesis recently announced that it has received 150 million yuan in the B + round of financing. The investors are Shenzhen Capital Group Company and GTJA Investment Group. It is worth noting that this is also the first financing event in the field of smart healthcare in 2020.

Nuanyang Health has garnered tens of millions of yuan in a Pre-A financing round jointly invested by China Growth Capital and Rongan Venture Capital. Ruiling Capital served as the sole financial advisor.

MGI Tech announced the completion of one billion US dollars Series B financing round led by IDG Capital. This was China’s largest-ever funding round in the field of gene sequencing. CPE, Shanghai Guofang FoFs, Huaxing New Economic Fund, Huatai Zijin Investment, as well as existing investors CITIC Securities, Green Pine Capital Partners and other venture capital firms also participated in the roun

Bio-Thera announced that on May 26, 2020, the company received the “Clinical Trial Notice” issued by the State Drug Administration regarding the company’s drug BAT1308 injection.

On May 26, it was reported that the Shanghai Ninth People’s Hospital launched an online hospital to support online follow-up consultations, online consultations, health records, prescriptions and other services.

Sanyou Bio has completed its Series A financing round raising tens of millions of yuan. This round of financing was jointly invested by Haier Medical and Liferiver Biotech.

On May 19, the General Office of the Shanghai Municipal People’s Government issued Several Opinions on Accelerating the Development of the Municipal Senior Care Industry.